Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD Announces Webcast of Annual Meeting of Shareholders BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a live webcast of its...

Key Takeaway: BD (Becton, Dickinson and Company) has announced it will host a live webcast of its Annual Meeting of Shareholders on January 24, 2023. The webcast can be accessed through the company’s investor relations website. Following the meeting, a replay will be available, allowing stakeholders to catch up on discussions and updates from the event. BD emphasizes its role in advancing medical technology and improving healthcare delivery worldwide.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is a leading global medical technology company.
  • The webcast will provide stakeholders with important updates.
  • BD is committed to advancing health care technology and solutions.

Full Press Release Details

FRANKLIN LAKES, N.J. , Jan. 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 24, 2023 , at 1 p.m. (ET) .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Francesca DeMartino
VP, Public Relations SVP, Head of Investor Relations
858.617.2361 201.847.5743
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When is BD's Annual Meeting of Shareholders?

BD's Annual Meeting of Shareholders is on January 24, 2023, at 1 p.m. ET.

How can I access the BD webcast?

The webcast can be accessed on the BD investor relations website at investors.bd.com.

Will there be a replay of the BD event?

Yes, a replay will be available on the investor relations website after the event.

What is BD known for?

BD is a top global medical technology company focused on improving health care.

How many employees does BD have?

BD has approximately 77,000 employees worldwide.

Last updated: Jan 6, 2023